Clinical Trials Logo

Clinical Trial Summary

The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atopic disorders should be investigated. An optional additional module "Bioanalytic" shall provide insights into further connections regarding immunology, genetics and microbiome.


Clinical Trial Description

The prevalence of atopic disorders increased in the western countries within the past decades. Atopic disorders are among others: food allergy, atopic dermatitis, allergic rhinitis, bronchial asthma, chronic spontaneous urticaria, eosinophilic esophagitis and chronic rhinosinusitis with nasal polyposis. Seriously affected patients often have coexisting atopic disorders. In fact, 60-75% of the patients with a severe atopic dermatitis also suffer from an allergic rhinoconjunctivitis and 40-50% from bronchial asthma. This leads to a decreased quality of life (LG) especially in seriously affected patients. The treatment of atopic disorders is not standardized yet. The Atopy Registry should promote the creation of a Germany-wide registry for different atopic disorders.Furthermore, the registry should characterize the medical care of patients with atopic disorders (patient satisfaction, therapy order, treatment success). This study serves as a longterm observation und is designed to compare different systemic therapies, since head-to-head studies regarding the efficacy are still missing. The analysis of biomaterial is involved to state possible correlations between endotype and phenotype. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05334940
Study type Observational [Patient Registry]
Source Charite University, Berlin, Germany
Contact Margitta Worm, Prof.
Phone +49 30 450 518105
Email margitta.worm@charite.de
Status Recruiting
Phase
Start date December 8, 2022
Completion date August 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05932953 - Skin Tolerance of Medical Devices for Diabetes Monitoring and Treatment in Children With Type 1 Diabetes
Active, not recruiting NCT03409367 - A Community-based Assessment of Skin Care, Allergies, and Eczema N/A
Completed NCT03050151 - Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis Phase 1
Completed NCT04397081 - Atopic Diseases & Human Papilloma Virus
Completed NCT03997175 - Effect of Modified Playground Environment on Health, Particularly Immune System N/A